Homocysteine levels, genetic background, and cognitive impairment in Parkinson’s disease

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1432-1459
Umfang
Online-Ressource
Sprache
Englisch
Anmerkungen
online resource.

Erschienen in
Homocysteine levels, genetic background, and cognitive impairment in Parkinson’s disease ; day:28 ; month:9 ; year:2022 ; pages:1-9
Journal of neurology ; (28.9.2022), 1-9

Urheber
Periñán, María Teresa
Macías-García, Daniel
Jesús, Silvia
Martín-Rodríguez, Juan Francisco
Muñoz-Delgado, Laura
Jimenez-Jaraba, Maria Valle
Buiza-Rueda, Dolores
Bonilla-Toribio, Marta
Adarmes-Gómez, Astrid Daniela
Gómez-Garre, Pilar
Mir, Pablo
Beteiligte Personen und Organisationen
SpringerLink (Online service)

DOI
10.1007/s00415-022-11361-y
URN
urn:nbn:de:101:1-2022121621003824477770
Rechteinformation
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
15.08.2025, 07:22 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • Periñán, María Teresa
  • Macías-García, Daniel
  • Jesús, Silvia
  • Martín-Rodríguez, Juan Francisco
  • Muñoz-Delgado, Laura
  • Jimenez-Jaraba, Maria Valle
  • Buiza-Rueda, Dolores
  • Bonilla-Toribio, Marta
  • Adarmes-Gómez, Astrid Daniela
  • Gómez-Garre, Pilar
  • Mir, Pablo
  • SpringerLink (Online service)

Ähnliche Objekte (12)

Advanced brain aging in Parkinson’s disease with cognitive impairment

Advanced brain aging in Parkinson’s disease with cognitive impairment

Resting-state EEG measures cognitive impairment in Parkinson’s disease

Resting-state EEG measures cognitive impairment in Parkinson’s disease

Mild Cognitive Impairment in Parkinson’s Disease—What Is It?

Mild Cognitive Impairment in Parkinson’s Disease—What Is It?

Mild cognitive impairment in Parkinson’s disease: a distinct clinical entity?

Mild cognitive impairment in Parkinson’s disease: a distinct clinical entity?

Paeoniflorin ameliorates cognitive impairment in Parkinson’s disease via JNK/p53 signaling

Paeoniflorin ameliorates cognitive impairment in Parkinson’s disease via JNK/p53 signaling

Misfolded protein deposits in Parkinson’s disease and Parkinson’s disease-related cognitive impairment, a [11C]PBB3 study

Misfolded protein deposits in Parkinson’s disease and Parkinson’s disease-related cognitive impairment, a [11C]PBB3 study

Theory of mind in mild cognitive impairment and Parkinson’s disease: The role of memory impairment

Theory of mind in mild cognitive impairment and Parkinson’s disease: The role of memory impairment

Nonmotor symptom burden grading as predictor of cognitive impairment in Parkinson’s disease

Nonmotor symptom burden grading as predictor of cognitive impairment in Parkinson’s disease

Gut microbiome is not associated with mild cognitive impairment in Parkinson’s disease

Gut microbiome is not associated with mild cognitive impairment in Parkinson’s disease

Metaproteogenomic analysis of saliva samples from Parkinson’s disease patients with cognitive impairment

Metaproteogenomic analysis of saliva samples from Parkinson’s disease patients with cognitive impairment

Cognitive reorganization in patients with Parkinson’s Disease and Mild Cognitive Impairment: a neuropsychological network approach

Cognitive reorganization in patients with Parkinson’s Disease and Mild Cognitive Impairment: a neuropsychological network approach

Altered regional homogeneity of prefrontal cortex in Parkinson’s disease with mild cognitive impairment

Altered regional homogeneity of prefrontal cortex in Parkinson’s disease with mild cognitive impairment

Verbundene Objekte